An ISO9001 Certified Supplier of Pharmaceutical Ingredients and Specialty Chemicals

INPEFA®

Drug Information Related Patent

Hold Company

LEXICON PHARMS INC

Learn More

Dosage and Administration

TABLET;ORAL

Specification

200MG; 400MG

Indication

INPEFA® is used to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits.

Use

Instructions for Use

API

SOTAGLIFLOZIN

API Structure

We Supply

SOTAGLIFLOZIN

Note:

null

Note:

null

Note:

null

Drug Patent

Patent No	Expiration Date
7781577	2028/5/4
8217156	2030/10/7
8476413	2028/5/29

API Patent

Patent No	Expiration Date
8217156	2030/10/7

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION

Tel:
E-mail:
Address:
WhatsAPP

Member of

CERTIFICATION